AstraZeneca (AZN.L) has announced a $2.5 billion investment in a research and development (R&D) hub in Beijing, reinforcing its commitment to China—its second-largest market—following recent challenges, including the arrest of…
China has announced plans to refine its centralized medicine procurement policies, reinforcing quality evaluations and regulatory oversight to ensure public confidence in the country’s pharmaceutical supply chain, according to an…
China and Korea have committed $4 million to the Africa Centres for Disease Control and Prevention (Africa CDC) to mitigate immediate healthcare funding shortfalls.
This contribution follows financial gaps triggered by…